Last Updated: June 27, 2026

Suppliers and packagers for sofdra


✉ Email this page to a colleague

« Back to Dashboard


sofdra

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Botanix Sb SOFDRA sofpironium bromide GEL, METERED;TOPICAL 217347 NDA Botanix SB Inc. 83723-010-50 1 BOTTLE in 1 CARTON (83723-010-50) / 50 mL in 1 BOTTLE 2024-08-06
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for sofdra

Last updated: June 4, 2026

Sofdra Suppliers: Who Manufactures and Supplies Sofdra Drug Products?

No complete, citable supplier/manufacturer dataset can be produced for “Sofdra” from the information provided.

What company makes Sofdra drug product?

Sofdra is not identifiable to a single, verifiable drug product (active ingredient, strength, dosage form, and FDA/EMA listing) in the provided inputs. Without that mapping, supplier identification would be speculative.

Which active ingredient is Sofdra?

No active ingredient or market authorization identifier is provided, so supplier lists cannot be reliably attributed.

Which dosage form is Sofdra?

No dosage form (tablet, capsule, solution, cream, injection, etc.) is specified, which blocks sourcing and contract-manufacturing profiling.

What manufacturers supply Sofdra ingredients (APIs) and intermediates?

API and intermediate suppliers are tied to the specific active ingredient and synthesis route. “Sofdra” is not mapped to a unique API in the provided inputs, so API sourcing cannot be stated as facts.

Are there multiple API sources for Sofdra?

Unverifiable without the specific API and manufacturing standards references.

What contract manufacturing organizations (CMOs) build Sofdra?

C(X)MO involvement depends on the specific product filing and manufacturing site list (e.g., FDA BLA/NDA/ANDA establishment listings or drug master file links). No filing or site information is provided.

Which facilities are approved to make Sofdra?

Cannot be determined without a defined product label/approval record.

What is the Orange Book status of Sofdra, and what suppliers are listed there?

Orange Book listings require a specific FDA application number or NDC/active ingredient mapping. No such mapping is provided.

Does Sofdra have listed patents and approved ANDAs?

Not determinable without identifying the product in FDA databases.

Who supplies Sofdra to wholesalers and pharmacies (US distribution)?

Distributor networks require product identity tied to NDC, labeler, and wholesaler allocation data. No identifiers are provided.

What NDC labeler is Sofdra under?

Unknown based on the inputs.

What is Sofdra’s regulatory footprint (FDA, EMA, other jurisdictions) that drives supplier selection?

Regulatory footprint drives which sites are qualified. No geography, regulator, or approval record is supplied.

Is Sofdra marketed in the US or EU?

Not stated.

How does Sofdra compare with similar-named drugs in supplier databases?

Without the active ingredient, “Sofdra” can match multiple possible strings or branded naming variations, increasing misidentification risk. Supplier attribution cannot be made on name alone.

Key Takeaways

  • A verified supplier roster for “Sofdra” cannot be produced because the drug is not mapped to an identifiable active ingredient, dosage form, and regulatory product record in the provided inputs.
  • Supplier, CMO, API source, and distributor answers require a specific, uniquely identified product.

FAQs

  1. What is the active ingredient in Sofdra?
  2. What is Sofdra’s FDA application number or NDC?
  3. Who is the labeler/holder for Sofdra?
  4. Which sites are approved to manufacture Sofdra?
  5. Is Sofdra supplied by multiple API manufacturers or a single source?

References

  1. None.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.